Copyright: ©Author(s) 2026.
World J Transplant. Jun 18, 2026; 16(2): 119737
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.119737
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.119737
Table 2 Risk-of-bias summary
| Ref. | Randomization | Deviations | Missing data | Outcome measurement | Selective reporting | Overall |
| Fayed et al[9], 2016 | Unclear risk | Low risk | Low risk | Some concerns | Low risk | Some concerns |
| Yang et al[10], 2024 | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Zhang et al[11], 2021 | Not applicable1 | Not applicable1 | Not applicable1 | Not applicable1 | Not applicable1 | Moderate risk |
| Zhang et al[12], 2022 | Not applicable1 | Not applicable1 | Not applicable1 | Not applicable1 | Not applicable1 | Moderate risk |
- Citation: Kulsum S, Khan SA, Dahiya DS, Ali H, Hayat U, Khalaf M, Ali H. Impact of dexmedetomidine administration on serum creatinine levels following liver transplantation: A systematic review and meta-analysis. World J Transplant 2026; 16(2): 119737
- URL: https://www.wjgnet.com/2220-3230/full/v16/i2/119737.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i2.119737